Literature DB >> 23757279

Structural alterations of faecal and mucosa-associated bacterial communities in irritable bowel syndrome.

Ana Durbán1, Juan J Abellán, Nuria Jiménez-Hernández, Patricia Salgado, Marta Ponce, Julio Ponce, Vicente Garrigues, Amparo Latorre, Andrés Moya.   

Abstract

Irritable bowel syndrome (IBS) is the most common functional gastrointestinal disorder in western countries. Previous studies on IBS, mostly based on faecal samples, suggest alterations in the intestinal microbiota. However, no consensus has been reached regarding the association between specific bacteria and IBS. We explore the alterations of intestinal bacterial communities in IBS using massive sequencing of amplified 16S rRNA genes. Mucosal biopsies of the ascending and descending colon and faeces from 16 IBS patients and 9 healthy controls were analysed. Strong inter-individual variation was observed in the composition of the bacterial communities in both patients and controls. These communities showed less diversity in IBS cases. There were larger differences in the microbiota composition between biopsies and faeces than between patients and controls. We found a few over-represented and under-represented taxa in IBS cases with respect to controls. The detected alterations varied by site, with no changes being consistent across sample types.
© 2012 Society for Applied Microbiology and Blackwell Publishing Ltd.

Entities:  

Year:  2012        PMID: 23757279     DOI: 10.1111/j.1758-2229.2012.00327.x

Source DB:  PubMed          Journal:  Environ Microbiol Rep        ISSN: 1758-2229            Impact factor:   3.541


  37 in total

Review 1.  Crosstalk at the mucosal border: importance of the gut microenvironment in IBS.

Authors:  Lena Öhman; Hans Törnblom; Magnus Simrén
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-12-02       Impact factor: 46.802

Review 2.  Brain-gut microbiome interactions and functional bowel disorders.

Authors:  Emeran A Mayer; Tor Savidge; Robert J Shulman
Journal:  Gastroenterology       Date:  2014-02-28       Impact factor: 22.682

3.  Relationship Between Microbiota of the Colonic Mucosa vs Feces and Symptoms, Colonic Transit, and Methane Production in Female Patients With Chronic Constipation.

Authors:  Gopanandan Parthasarathy; Jun Chen; Xianfeng Chen; Nicholas Chia; Helen M O'Connor; Patricia G Wolf; H Rex Gaskins; Adil E Bharucha
Journal:  Gastroenterology       Date:  2015-10-13       Impact factor: 22.682

Review 4.  Close association between intestinal microbiota and irritable bowel syndrome.

Authors:  W-T Fan; C Ding; N-N Xu; S Zong; P Ma; B Gu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-08-07       Impact factor: 3.267

Review 5.  The microbiota-gut-brain axis in functional gastrointestinal disorders.

Authors:  Giada De Palma; Stephen M Collins; Premysl Bercik
Journal:  Gut Microbes       Date:  2014-06-12

Review 6.  New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists.

Authors:  Amy E Foxx-Orenstein
Journal:  Therap Adv Gastroenterol       Date:  2016-02-21       Impact factor: 4.409

Review 7.  Methodological issues in the study of intestinal microbiota in irritable bowel syndrome.

Authors:  Valentina Taverniti; Simone Guglielmetti
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

8.  Fecal Microbiota Transplantation: A Review of Emerging Indications Beyond Relapsing Clostridium difficile Toxin Colitis.

Authors:  Woo Jung Lee; Lakshmi D N Lattimer; Sindu Stephen; Marie L Borum; David B Doman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-01

9.  Visceral hypersensitive rats share common dysbiosis features with irritable bowel syndrome patients.

Authors:  Xiao-Yan Zhou; Ming Li; Xia Li; Xin Long; Xiu-Li Zuo; Xiao-Hua Hou; Ying-Zi Cong; Yan-Qing Li
Journal:  World J Gastroenterol       Date:  2016-06-14       Impact factor: 5.742

10.  Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.

Authors:  Nitsan Maharshak; Yehuda Ringel; David Katibian; Ashley Lundqvist; R Balfour Sartor; Ian M Carroll; Tamar Ringel-Kulka
Journal:  Dig Dis Sci       Date:  2018-05-17       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.